0000899243-17-019220.txt : 20170727 0000899243-17-019220.hdr.sgml : 20170727 20170727183557 ACCESSION NUMBER: 0000899243-17-019220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170725 FILED AS OF DATE: 20170727 DATE AS OF CHANGE: 20170727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yanchik Joseph A., III CENTRAL INDEX KEY: 0001618154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 17987411 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-25 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001618154 Yanchik Joseph A., III C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139 1 1 0 0 See Remarks Stock Option (right to buy) 13.00 2017-07-25 4 A 0 157449 0.00 A 2027-07-24 Common Stock 157449 157449 D This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from July 25, 2017. President and Chief Executive Officer and Director /s/ Kira A. Nelson, attorney-in-fact for Joseph A. Yanchik, III 2017-07-27